To measure or not to measure? That is the NPS question

Journal of Analytical Toxicology

Volumn 40, Issue 4, 2016, Pages 318-320

  Gerostamoulos, Dimitri ^a,b   Elliott, Simon ^c   Walls, H Chip ^d   Peters, Frank T ^e   Lynch, Matthew ^a,b   Drummer, Olaf H ^a,b  

^a VICTORIAN INSTITUTE OF FORENSIC MEDICINE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Inverness Medical Innovations   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DRUG METABOLITE; ILLICIT DRUG; METHAMPHETAMINE; PSYCHOTROPIC AGENT; STREET DRUG;

ANALYTIC METHOD; AUTOPSY; CORONER; DRUG METABOLISM ASSAY; FORENSIC PATHOLOGY; FORENSIC TOXICOLOGY; GAS CHROMATOGRAPHY; HUMAN; LETTER; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICOLEGAL ASPECT; PATHOLOGIST; PHARMACODYNAMICS; PREVALENCE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STANDARD; SUDDEN DEATH; TRENDS;

FORENSIC TOXICOLOGY; HUMANS; PSYCHOTROPIC DRUGS; STREET DRUGS;

EID: 84964804237     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkw013     Document Type: Letter

References (17)

1. Zawilska, J.B., Andrzejczak, D. (2015) Next generation of novel psychoactive substances on the horizon-a complex problem to face. Drug and Alcohol Dependence, 157, 1-7.
2. Karila, L., Megarbane, B., Cottencin, O., Lejoyeux, M. (2015) Synthetic cathinones: a new public health problem. Current Neuropharmacology, 13, 12-20.
3. EMCDDA-Europol 2014 Annual Report on the implementation of Council Decision 2005/387/JHA, Luxembourg, 2015.
4. World Drug Report 2015, United Nations Office on Drugs and Crime. 2015, United Nations publication, Sales No. E.15.XI.6, Vienna, Austria.
5. Soh, Y.N., Elliott, S. (2014) An investigation of the stability of emerging new psychoactive substances. Drug Testing and Analysis, 6, 696-704.
6. Castaneto, M.S., Gorelick, D.A., Desrosiers, N.A., Hartman, R.L., Pirard, S., Huestis, M.A. (2014) Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug and Alcohol Dependence, 144, 12-41.
7. Wohlfarth, A., Scheidweiler, K.B., Chen, X., Liu, H.F., Huestis, M.A. (2013) Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search. Analytical Chemistry, 85, 3730-3738.
8. Banister, S.D., Stuart, J., Kevin, R.C., Edington, A., Longworth, M., Wilkinson, S.M., et al. (2015) Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. ACS Chemical Neuroscience, 6, 1445-1458.
9. Banister, S.D., Moir, M., Stuart, J., Kevin, R.C., Wood, K.E., Longworth, M., et al. (2015) Pharmacology of indole and indazole synthetic cannabinoid designer drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA. ACS Chemical Neuroscience, 6, 1546-1559.
10. Huestis, M.A., Cone, E.J. (2007) Methamphetamine disposition in oral fluid, plasma, and urine. Annals of the New York Academy of Sciences, 1098, 104-121.
11. Huestis, M.A., Darwin, W.D., Shimomura, E., Lalani, S.A., Trinidad, D.V., Jenkins, A.J., et al. (2007) Cocaine and metabolites urinary excretion after controlled smoked administration. Journal of Analytical Toxicolology, 31, 462-468.
12. Chu, M.T., Gerostamoulos, D., Beyer, J., Drummer, O.H. An investigation into post-mortem changes in blood Δ9-tetrahydro-cannabinnol (THC) concentrations of deceased cannabis users. In: The International Association of Forensic Toxicologists Annual Meeting, Hamamatsu, Japan, 2012.
13. Kronstrand, R., Thelander, G., Lindstedt, D., Roman, M., Kugelberg, F.C. (2014) Fatal intoxications associated with the designer opioid AH-7921. Journal of Analytical Toxicology, 38, 599-604.
14. Elliott, S.P., Brandt, S.D., Wallach, J., Morris, H., Kavanagh, P.V. (2015) First reported fatalities associated with the 'research chemical' 2-methoxydiphenidine. Journal of Analytical Toxicology, 39, 287-293.
15. Sellors, K., Jones, A., Chan, B. (2014) Death due to intravenous use of alpha-pyrrolidinopentiophenone. The Medical Journal of Australia, 201, 601-603.
16. Gerostamoulos, D., Drummer, O.H., Woodford, N.W. (2015) Deaths linked to synthetic cannabinoids. Forensic Science, Medicine, and Pathology, 11, 478.
17. Trecki, J., Gerona, R.R., Schwartz, M.D. (2015) Synthetic cannabinoid-related illnesses and deaths. The New England Journal of Medicine, 373, 103-107.